Blues TEC Issues Negative Review Of Cyberonics’ VNS Therapy For Depression
This article was originally published in The Gray Sheet
Executive Summary
The BlueCross BlueShield Association's Technology Evaluation Center (TEC) says there is insufficient evidence to conclude that Cyberonics' VNS Therapy improves net health outcomes of patients with treatment-resistant depression